A scientific article co-authored by Barbara Pietrucha, professor of the CMHI, has been published in the prestigious journal – Lancet Neurology.

The publication concerns an innovative method of treating patients with ataxia-telangiectasia (A-T) syndrome, involving the administration of dexamethasone in the patient’s own blood cells.

Currently, there are no effective treatments for A-T, which is why the discovery of a new therapeutic method is a huge breakthrough.

The new type of therapy not only alleviates neurological symptoms, as has been the case to date, but also slows down the progression of the disease by approximately 3.5 years, which significantly improves the functioning of the youngest patients. This discovery therefore brings about a real improvement in the quality of life of patients and their families.

Prof. Barbara Pietrucha has been involved in A-T research for many years, and her commitment goes far beyond scientific activity. In 2004, Prof. Pietrucha initiated the establishment of the „Razem Zdążymy” Foundation.

This publication is a significant contribution to the development of science and medicine.